Alpha Cognition Inc. (ACOG) stock
ACOGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3083% above fair value
$8.85+0.25 (+2.91%)
Close on Nov 19, 2026Market cap $192.73MP/E –Yield –
Alpha Cognition free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Alpha Cognition's free cash flow for the twelve months ending Jun 30, 2026 was -$31.18M. For fiscal 2025 it was -$20.67M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$20.67M | – |
| FY2024 | Dec 31, 2024 | -$7.78M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.96M | – |
| Q1 FY2026 | Mar 31, 2026 | -$11.80M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.05M | – |
| Q3 FY2025 | Sep 30, 2025 | -$5.36M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.15M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.11M | – |
See a number that looks wrong?